To improve municipal PA (Pharmaceutical Assistance) and pharmaceutical care for SUS users, we developed a project to restructure the PA in Campo Mourão- Paraná. This project contemplates the dispensing of insulin, which will serve all patients with Diabetes Mellitus, who use this medication, promoting the following objectives:
The provision of this presentation for NPH and Regular insulins was incorporated into the Unified Health System (SUS) in 2017 after the recommendation report No. adherence of patients to the treatment of Diabetes Mellitus. Access is being gradually expanded through tripartite agreements and publication of Technical Notes that consider eligible groups and proportionality of availability for use and distribution of pens in 2019 (15%), 2020 (30%), 2021 (50%) and 2022 ( 70%). This gradual implementation was an option to face the challenges of network organization and distribution and storage logistics.
The use of devices in pens for insulin delivery in insulin-dependent diabetics provides greater precision and safety in the application, in addition to greater comfort and practicality. Pens are a technology that has numerous advantages and benefits: 90% of pen users say they need less assistance for application; 97% of US physicians believe that administering insulin with a pen is better than using vials, syringes, and ampoules; 67% of people with diabetes who adopted the insulin pen have fewer episodes of hypoglycemia; 90% of people with diabetes consider the pen to be more discreet, faster and easier to use, according to studies in Italy, the USA and Ireland;
However, in relation to insulin vials, the use of insulin pens is a technology that requires more storage space, and it is necessary to keep the medication under refrigeration. To comply with the project and the Ministry of Health's dispensing protocol, it will be necessary to purchase 5 more refrigerators.
- All insulin syringes will be dispensed under the direct supervision of the pharmacist: In Basic Health Units (UBS): Right after the meetings of the Hiperdia program (monitoring program for all Diabetic and Hypertensive patients), according to the schedule; In municipal pharmacies, as needed.